首页 > 市场调查报告书 > 製药

基因治疗学和RNAi

市场调查报告书

商品编码

1401820

反义和 RNAI 治疗市场，按技术、按应用、按给药途径、按国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测

Antisense & RNAI Therapeutics Market, By Technology, By Application, By Route of Administration, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

出版日期: 2024年01月01日 | 出版商:

AnalystView Market Insights | 英文 316 Pages | 商品交期: 2-3个工作天内

价格

简介目录图表

报告要点

2022 年反义和 RNAI 治疗市场规模为 38 亿美元，2023 年至 2030 年CAGR为 19.1%。

反义和RNAI治疗市场-市场动态

反义和 RNAi 疗法在治疗罕见疾病方面的变革性影响，推动市场需求

推动市场的主要因素是反义和 RNAi 疗法在治疗罕见疾病方面的变革性影响。透过采用基因沉默，这些疗法可以防止疾病相关蛋白质的产生，特别有利于脊髓性肌肉萎缩症和杂合子家族性高胆固醇血症等疾病。 RNAi 治疗以致病 mRNA 为目标，其精确性和选择性使其成为罕见疾病的先进且受欢迎的治疗方法。 RNAi 疗法需求的激增是一个关键驱动因素，再加上研发投资的增加和有前景的管道产品，共同推动了市场扩张。

反义和 RNAI 治疗市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2023-2030 年）每年将以 19.1% 左右的CAGR成长

基于技术细分，预计反义RNA将在2022年显示最大的市场份额

依给药途径细分，2022年遗传疾病为主导类型

按地区划分，北美是 2022 年的主要收入来源

反义和RNAI治疗市场-細項分析：

全球反义和 RNAI 治疗市场根据技术、应用、给药途径和地区进行细分。

市场依技术分为两类：RNA干扰和反义RNA。 2022年，反义RNA部门占了最大的收入份额。该部门主要在创收方面处于领先地位，并且正在积极进行管理各种条件的试验。该技术用于调节蛋白质和基因表达，在心血管、呼吸系统、神经退化性疾病和遗传性疾病方面具有广泛的应用，预计将出现显着的细分市场成长。例如，麻省大学陈医学院于 2021 年 12 月进行的一项临床试验证明，使用反义寡核苷酸可以安全抑制突变型肌萎缩侧索硬化症 (ALS) 基因。

根据给药途径，市场分为九类：遗传疾病、癌症、传染病、神经退化性疾病、心臟代谢和肾臟疾病、眼部疾病、呼吸系统疾病、皮肤疾病等。 2022 年，遗传性疾病领域的收入份额最高。控制杜氏肌肉营养不良症 (DMD) 和脊髓性肌肉萎缩症等疾病的需求日益增长，预计将推动寡核苷酸产品的使用。寡核苷酸药物领域的研究工作正在迅速扩大，这从越来越多的研究中可以看出。公司正在寻求监管部门批准用于治疗遗传疾病的产品。例如，2019 年 12 月，针对 DMD 患者的反义寡核苷酸疗法 golodirsen 获得了美国食品药物管理局 (FDA) 的批准。

反义和 RNAI 治疗市场 - 地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太地区以及中东和非洲地区。这些区域根据开展业务的国家进一步划分。

反义与RNAI治疗市场-竞争格局：

在反义和 RNAi 治疗市场中，公司部署各种关键策略来巩固自己的地位。他们优先考虑广泛的研究和开发，投资尖端技术以找出精确的基因标靶并创造有效的治疗分子。管道多元化仍然是首要任务，旨在涵盖多种疾病并扩大市场范围。与研究机构和行业同行的合作伙伴关係可加快进展并促进资源共享。同时，公司确保严格遵守监管标准，并有效完成审批流程。批准后的策略商业化计划，包括有针对性的行销和无障碍倡议，对于成功采用至关重要。此外，递送系统的持续进步是优化治疗效果的关键焦点。这些综合策略共同推动了医疗保健领域反义和 RNAi 疗法的进步和接受。公司透过专门的进步利用反义和 RNAi 技术。

介绍
- 按地理位置分類的细分市场占有率分析
北美洲
- 概述
- 北美反义和 RNAI 疗法主要製造商
- 北美市场规模和预测（按国家）
- 北美市场规模和预测（按技术）
- 北美市场规模和预测（按应用）
- 北美市场规模与预测（按管理途径）
- 我们
- 加拿大
欧洲
- 概述
- 欧洲反义和 RNAI 疗法主要製造商
- 欧洲市场规模和预测（按国家）
- 欧洲市场规模与预测（按技术）
- 欧洲市场规模和预测（按应用）
- 欧洲市场规模与预测（按管理途径）
- 德国
- 义大利
- 英国
- 法国
- 俄罗斯
- 荷兰
- 瑞典
- 波兰
- 欧洲其他地区
亚太地区 (APAC)
- 概述
- 亚太地区反义和 RNAI 疗法主要製造商
- 亚太地区市场规模与预测（按国家）
- 亚太地区市场规模与预测（按技术）
- 亚太地区市场规模与预测（按应用）
- 亚太地区市场规模与预测（依管理途径）
- 印度
- 中国
- 日本
- 韩国
- 澳洲
- 泰国
- 印尼
- 菲律宾
- 亚太地区其他地区
拉丁美洲
- 概述
- 拉丁美洲反义和 RNAI 疗法主要製造商
- 拉丁美洲市场规模与预测（按国家）
- 拉丁美洲市场规模与预测（按技术）
- 拉丁美洲市场规模与预测（按应用）
- 拉丁美洲市场规模与预测（按管理途径）
- 巴西
- 墨西哥
- 阿根廷
- 哥伦比亚
- 拉丁美洲其他地区
中东和非洲
- 概述
- 中东和非洲反义和RNAI疗法主要製造商
- 中东和非洲市场规模及预测（按国家）
- 中东和非洲市场规模及预测（按技术）
- 中东和非洲市场规模及预测（按应用）
- 中东和非洲市场规模及预测（按管理途径）
- 沙乌地阿拉伯
- 阿拉伯聯合大公国
- 以色列
- 土耳其
- 阿尔及利亚
- 埃及
- MEA 的其余部分

第 11 章：主要供应商分析 - 反义与 RNAI 治疗产业

竞争仪表板
公司简介
- GSK plc
- Olix Pharmaceuticals, Inc.
- Sanofi
- Alnylam Pharmaceuticals, Inc.
- Arbutus Biopharma
- Benitec Biopharma Inc.
- Silence Therapeutics
- Ionis Pharmaceuticals, Inc
- Bio-Path Holdings Inc.
- Antisense Therapeutics Limited.
- Others

第 12 章：360 度分析师视角

第 13 章：附录

研究方法论
参考
缩写
免责声明
联络我们

简介目录图表

Product Code: ANV2006

REPORT HIGHLIGHT

Antisense & RNAI Therapeutics Market size was valued at USD 3,800 Million in 2022, expanding at a CAGR of 19.1% from 2023 to 2030.

Antisense technology, acknowledged for gene expression manipulation, stands as a successful treatment avenue for numerous medical conditions. The use of Antisense and RNAi therapies for rare diseases has notably improved therapeutic outcomes. For example, Antisense Oligonucleotides (ASOs) have gained approval for treating rare neurological conditions such as Duchenne muscular dystrophy (DMD) and spinal muscular atrophy (SMA), signaling anticipated growth in the upcoming years. Additionally, augmented R&D funding and a robust product pipeline are expected to drive market expansion. For instance, in January 2023, Agilent invested USD 725 million in expanding manufacturing capabilities for nucleic acid-based therapeutics, including antisense therapies. The scarcity of global treatment options for rare diseases has spurred increased funding and research endeavors focused on developing novel treatments for these conditions.

Antisense & RNAI Therapeutics Market- Market Dynamics

Transformative impact of antisense and RNAi therapeutics in treating rare diseases to propel market demand

The primary factors driving the market are the transformative impact of antisense and RNAi therapeutics in treating rare diseases. By employing gene silencing, these therapies prevent the production of disease-related proteins, notably benefiting conditions like spinal muscular atrophy and heterozygous familial hypercholesterolemia. The precision and selectivity of RNAi treatments, which target disease-causing mRNA, position them as advanced and favored treatments for rare ailments. This surge in demand for RNAi therapeutics acts as a key driver, complemented by increased R&D investment and promising pipeline products, collectively propelling market expansion.

Antisense & RNAI Therapeutics Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 19.1% over the forecast period (2023-2030)

Based on Technology segmentation, antisense RNA was predicted to show maximum market share in the year 2022

Based on Route of Administration segmentation, genetic disease was the leading type in 2022

On the basis of region, North America was the leading revenue generator in 2022

Antisense & RNAI Therapeutics Market- Segmentation Analysis:

The Global Antisense & RNAI Therapeutics Market is segmented on the basis of Technology, Application, Route of Administration, and Region.

The market is divided into two categories based on Technology: RNA Interference and Antisense RNA. In 2022, the antisense RNA division represented the largest share of revenue. This segment has predominantly led in revenue generation and is actively undergoing trials for managing various conditions. Utilized for regulating both protein and gene expression, this technology exhibits broad applications across cardiovascular, respiratory, neurodegenerative, and genetic disorders, foreseeing significant segmental growth. For instance, a clinical trial at UMass Chan Medical School in December 2021 demonstrated the safe suppression of the mutant amyotrophic lateral sclerosis (ALS) gene using antisense oligonucleotides.

The market is divided into nine categories based on Route of Administration: Genetic Disease, Cancer, Infectious Disease, Neurodegenerative Disorders, Cardio Metabolic & Renal Disorders, Ocular Disorders, Respiratory Disorders, Skin Disorders and Others. The genetic disorder sector commanded the highest revenue share in 2022. The growing necessity to manage diseases like Duchenne muscular dystrophy (DMD) and spinal muscular atrophy is expected to drive the usage of oligonucleotide products. Research endeavors in the realm of oligonucleotide medications are rapidly expanding, evident from the increasing number of research studies. Companies are pursuing regulatory approvals for products designed to treat genetic diseases. For instance, in December 2019, golodirsen, an antisense oligonucleotide therapy for individuals afflicted with DMD, received approval from the Food and Drug Administration (FDA).

Antisense & RNAI Therapeutics Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Antisense & RNAI Therapeutics Market- Competitive Landscape:

In the Antisense & RNAi Therapeutics Market, companies deploy various key strategies to bolster their position. They prioritize extensive research and development, investing in cutting-edge technologies to pinpoint precise gene targets and create effective therapeutic molecules. Diversifying pipelines remains a top priority, aiming to encompass a wide array of diseases and broaden market reach. Collaborative partnerships with research institutions and industry counterparts expedite progress and facilitate resource sharing. Concurrently, companies ensure rigorous compliance with regulatory standards, efficiently navigating approval processes. Post-approval, strategic commercialization plans, inclusive of targeted marketing and accessibility initiatives, are vital for successful adoption. Furthermore, continuous advancements in delivery systems are a pivotal focus to optimize therapeutic efficacy. These comprehensive strategies collectively drive the progression and acceptance of antisense and RNAi therapies within the healthcare landscape. Companies capitalize on antisense & RNAi technologies through dedicated advancements.

Recent Developments:

In April 2020, Alnylam Pharmaceuticals, Inc. partnered with Blackstone, with Blackstone investing USD 2 billion to accelerate RNAi therapeutics advancement.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ANTISENSE & RNAI THERAPEUTICS MARKET KEY PLAYERS

GSK plc
Olix Pharmaceuticals, Inc.
Sanofi
Alnylam Pharmaceuticals, Inc.
Arbutus Biopharma
Benitec Biopharma Inc.
Silence Therapeutics
Ionis Pharmaceuticals, Inc
Bio-Path Holdings Inc.
Antisense Therapeutics Limited.
Others

GLOBAL ANTISENSE & RNAI THERAPEUTICS MARKET, BY TECHNOLOGY

RNA Interference
Antisense RNA

GLOBAL ANTISENSE & RNAI THERAPEUTICS MARKET, BY APPLICATION

Neurodegenerative Disorders
Cardio Metabolic & Renal Disorders
Genetic Disease
Cancer
Infectious Disease
Ocular Disorders
Respiratory Disorders
Skin Disorders
Others

GLOBAL ANTISENSE & RNAI THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION

Intravenous Injections
Intrathecal Injections
Subcutaneous Injections
Other Delivery Methods

GLOBAL ANTISENSE & RNAI THERAPEUTICS MARKET, BY REGION

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Antisense & RNAI Therapeutics Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Antisense & RNAI Therapeutics Market Snippet by Technology
- 2.1.2. Antisense & RNAI Therapeutics Market Snippet by Application
- 2.1.3. Antisense & RNAI Therapeutics Market Snippet by Route of Administration
- 2.1.4. Antisense & RNAI Therapeutics Market Snippet by Country
- 2.1.5. Antisense & RNAI Therapeutics Market Snippet by Region
2.2. Competitive Insights

3. Antisense & RNAI Therapeutics Key Market Trends

3.1. Antisense & RNAI Therapeutics Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Antisense & RNAI Therapeutics Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Antisense & RNAI Therapeutics Market Opportunities
3.4. Antisense & RNAI Therapeutics Market Future Trends

4. Antisense & RNAI Therapeutics Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Antisense & RNAI Therapeutics Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Antisense & RNAI Therapeutics Market Landscape

6.1. Antisense & RNAI Therapeutics Market Share Analysis, 2022
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Antisense & RNAI Therapeutics Market - By Technology

7.1. Overview
- 7.1.1. Segment Share Analysis, By Technology, 2022 & 2030 (%)
- 7.1.2. RNA Interference
- 7.1.3. Antisense RNA

8. Antisense & RNAI Therapeutics Market - By Application

8.1. Overview
- 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
- 8.1.2. Genetic Disease
- 8.1.3. Cancer
- 8.1.4. Infectious Disease
- 8.1.5. Neurodegenerative Disorders
- 8.1.6. Cardio Metabolic & Renal Disorders
- 8.1.7. Ocular Disorders
- 8.1.8. Respiratory Disorders
- 8.1.9. Skin Disorders
- 8.1.10. Others

9. Antisense & RNAI Therapeutics Market - By Route of Administration

9.1. Overview
- 9.1.1. Segment Share Analysis, By Route of Administration, 2022 & 2030 (%)
- 9.1.2. Intravenous Injections
- 9.1.3. Intrathecal Injections
- 9.1.4. Subcutaneous Injections
- 9.1.5. Other Delivery Methods

10. Antisense & RNAI Therapeutics Market- By Geography

10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
10.2. North America
- 10.2.1. Overview
- 10.2.2. Antisense & RNAI Therapeutics Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.2.7. U.S.
  - 10.2.7.1. Overview
  - 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.2.7.3. U.S. Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  - 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.2.7.5. U.S. Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.2.8. Canada
  - 10.2.8.1. Overview
  - 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.2.8.3. Canada Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  - 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.2.8.5. Canada Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.3. Europe
- 10.3.1. Overview
- 10.3.2. Antisense & RNAI Therapeutics Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.3.7. Germany
  - 10.3.7.1. Overview
  - 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.7.3. Germany Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  - 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.3.7.5. Germany Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.3.8. Italy
  - 10.3.8.1. Overview
  - 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.8.3. Italy Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  - 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.3.8.5. Italy Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.3.9. United Kingdom
  - 10.3.9.1. Overview
  - 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.9.3. United Kingdom Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  - 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.3.9.5. United Kingdom Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.3.10. France
  - 10.3.10.1. Overview
  - 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.10.3. France Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  - 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.3.10.5. France Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.3.11. Russia
  - 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.11.2. Russia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  - 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.3.11.4. Russia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.3.12. Netherlands
  - 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.12.2. Netherlands Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  - 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.3.12.4. Netherlands Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.3.13. Sweden
  - 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.13.2. Sweden Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  - 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.3.13.4. Sweden Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.3.14. Poland
  - 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.14.2. Poland Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  - 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.3.14.4. Poland Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.3.15. Rest of Europe
  - 10.3.15.1. Overview
  - 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.15.3. Rest of the Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  - 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.3.15.5. Rest of the Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Antisense & RNAI Therapeutics Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.4.7. India
  - 10.4.7.1. Overview
  - 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.7.3. India Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  - 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.4.7.5. India Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.4.8. China
  - 10.4.8.1. Overview
  - 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.8.3. China Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  - 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.4.8.5. China Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.4.9. Japan
  - 10.4.9.1. Overview
  - 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.9.3. Japan Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  - 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.4.9.5. Japan Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.4.10. South Korea
  - 10.4.10.1. Overview
  - 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.10.3. South Korea Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  - 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.4.10.5. South Korea Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.4.11. Australia
  - 10.4.11.1. Overview
  - 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.11.3. Australia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  - 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.4.11.5. Australia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.4.12. Thailand
  - 10.4.12.1. Overview
  - 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.12.3. Thailand Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  - 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.4.12.5. Thailand Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.4.13. Indonesia
  - 10.4.13.1. Overview
  - 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.13.3. Indonesia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  - 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.4.13.5. Indonesia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.4.14. Philippines
  - 10.4.14.1. Overview
  - 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.14.3. Philippines Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  - 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.4.14.5. Philippines Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.4.15. Rest of APAC
  - 10.4.15.1. Overview
  - 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.15.3. Rest of APAC Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  - 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.4.15.5. Rest of APAC Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Antisense & RNAI Therapeutics Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.5.7. Brazil
  - 10.5.7.1. Overview
  - 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.5.7.3. Brazil Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  - 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.5.7.5. Brazil Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.5.8. Mexico
  - 10.5.8.1. Overview
  - 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.5.8.3. Mexico Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  - 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.5.8.5. Mexico Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.5.9. Argentina
  - 10.5.9.1. Overview
  - 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.5.9.3. Argentina Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  - 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.5.9.5. Argentina Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.5.10. Colombia
  - 10.5.10.1. Overview
  - 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.5.10.3. Colombia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  - 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.5.10.5. Colombia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.5.11. Rest of LATAM
  - 10.5.11.1. Overview
  - 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.5.11.3. Rest of LATAM Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  - 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.5.11.5. Rest of LATAM Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Antisense & RNAI Therapeutics Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.6.7. Saudi Arabia
  - 10.6.7.1. Overview
  - 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.7.3. Saudi Arabia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  - 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.6.7.5. Saudi Arabia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.6.8. United Arab Emirates
  - 10.6.8.1. Overview
  - 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.8.3. United Arab Emirates Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  - 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.6.8.5. United Arab Emirates Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.6.9. Israel
  - 10.6.9.1. Overview
  - 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.9.3. Israel Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  - 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.6.9.5. Israel Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.6.10. Turkey
  - 10.6.10.1. Overview
  - 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.10.3. Turkey Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  - 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.6.10.5. Turkey Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.6.11. Algeria
  - 10.6.11.1. Overview
  - 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.11.3. Algeria Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  - 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.6.11.5. Algeria Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.6.12. Egypt
  - 10.6.12.1. Overview
  - 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.12.3. Egypt Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  - 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.6.12.5. Egypt Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.6.13. Rest of MEA
  - 10.6.13.1. Overview
  - 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.13.3. Rest of MEA Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  - 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.6.13.5. Rest of MEA Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Antisense & RNAI Therapeutics Industry

11.1. Competitive Dashboard
11.2. Company Profiles
- 11.2.1. GSK plc
- 11.2.2. Olix Pharmaceuticals, Inc.
- 11.2.3. Sanofi
- 11.2.4. Alnylam Pharmaceuticals, Inc.
- 11.2.5. Arbutus Biopharma
- 11.2.6. Benitec Biopharma Inc.
- 11.2.7. Silence Therapeutics
- 11.2.8. Ionis Pharmaceuticals, Inc
- 11.2.9. Bio-Path Holdings Inc.
- 11.2.10. Antisense Therapeutics Limited.
- 11.2.11. Others

12. 360 Degree Analyst View

13. Appendix

13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us

简介目录图表

List of Tables

TABLE List of data sources
TABLE Market drivers; Impact Analysis
TABLE Market restraints; Impact Analysis
TABLE Antisense & RNAI Therapeutics Market: Technology Snapshot (2022)
TABLE Segment Dashboard; Definition and Scope, by Technology
TABLE Global Antisense & RNAI Therapeutics Market, by Technology 2018-2030 (USD Million)
TABLE Antisense & RNAI Therapeutics Market: Application Snapshot (2022)
TABLE Segment Dashboard; Definition and Scope, by Application
TABLE Global Antisense & RNAI Therapeutics Market, by Application 2018-2030 (USD Million)
TABLE Antisense & RNAI Therapeutics Market: Route of Administration Snapshot (2022)
TABLE Segment Dashboard; Definition and Scope, by Route of Administration
TABLE Global Antisense & RNAI Therapeutics Market, by Route of Administration 2018-2030 (USD Million)
TABLE Antisense & RNAI Therapeutics Market: Regional snapshot (2022)
TABLE Segment Dashboard; Definition and Scope, by Region
TABLE Global Antisense & RNAI Therapeutics Market, by Region 2018-2030 (USD Million)
TABLE North America Antisense & RNAI Therapeutics Market, by Country, 2018-2030 (USD Million)
TABLE North America Antisense & RNAI Therapeutics Market, by Technology, 2018-2030 (USD Million)
TABLE North America Antisense & RNAI Therapeutics Market, by Application, 2018-2030 (USD Million)
TABLE North America Antisense & RNAI Therapeutics Market, by Route of Administration, 2018-2030 (USD Million)
TABLE Europe Antisense & RNAI Therapeutics Market, by Country, 2018-2030 (USD Million)
TABLE Europe Antisense & RNAI Therapeutics Market, by Technology, 2018-2030 (USD Million)
TABLE Europe Antisense & RNAI Therapeutics Market, by Application, 2018-2030 (USD Million)
TABLE Europe Antisense & RNAI Therapeutics Market, by Route of Administration, 2018-2030 (USD Million)
TABLE Asia Pacific Antisense & RNAI Therapeutics Market, by Country, 2018-2030 (USD Million)
TABLE Asia Pacific Antisense & RNAI Therapeutics Market, by Technology, 2018-2030 (USD Million)
TABLE Asia Pacific Antisense & RNAI Therapeutics Market, by Application, 2018-2030 (USD Million)
TABLE Asia Pacific Antisense & RNAI Therapeutics Market, by Route of Administration, 2018-2030 (USD Million)
TABLE Latin America Antisense & RNAI Therapeutics Market, by Country, 2018-2030 (USD Million)
TABLE Latin America Antisense & RNAI Therapeutics Market, by Technology, 2018-2030 (USD Million)
TABLE Latin America Antisense & RNAI Therapeutics Market, by Application, 2018-2030 (USD Million)
TABLE Latin America Antisense & RNAI Therapeutics Market, by Route of Administration, 2018-2030 (USD Million)
TABLE Middle East and Africa Antisense & RNAI Therapeutics Market, by Country, 2018-2030 (USD Million)
TABLE Middle East and Africa Antisense & RNAI Therapeutics Market, by Technology, 2018-2030 (USD Million)
TABLE Middle East and Africa Antisense & RNAI Therapeutics Market, by Application, 2018-2030 (USD Million)
TABLE Middle East and Africa Antisense & RNAI Therapeutics Market, by Route of Administration, 2018-2030 (USD Million)

List of Figures

FIGURE Antisense & RNAI Therapeutics Market Segmentation
FIGURE Market research methodology
FIGURE Value chain analysis
FIGURE Porter's Five Forces Analysis
FIGURE Market Attractiveness Analysis
FIGURE COVID-19 Impact Analysis
FIGURE Pre & Post COVID-19 Impact Comparision Study
FIGURE Competitive Landscape; Key company market share analysis, 2022
FIGURE Technology segment market share analysis, 2022 & 2030
FIGURE Technology segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Application segment market share analysis, 2022 & 2030
FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Route of Administration segment market share analysis, 2022 & 2030
FIGURE Route of Administration segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Regional segment market share analysis, 2022 & 2030
FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE North America Antisense & RNAI Therapeutics Market share and leading players, 2022
FIGURE Europe Antisense & RNAI Therapeutics Market share and leading players, 2022
FIGURE Asia Pacific Antisense & RNAI Therapeutics Market share and leading players, 2022
FIGURE Latin America Antisense & RNAI Therapeutics Market share and leading players, 2022
FIGURE Middle East and Africa Antisense & RNAI Therapeutics Market share and leading players, 2022
FIGURE North America market share analysis by country, 2022
FIGURE U.S. Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Canada Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Europe Antisense & RNAI Therapeutics Market share analysis by country, 2022
FIGURE Germany Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Spain Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Italy Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE France Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE UK Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Russia Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Netherlands Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Sweden Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Poland Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Rest of the Europe Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Asia Pacific Antisense & RNAI Therapeutics Market share analysis by country, 2022
FIGURE India Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE China Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Japan Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE South Korea Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Australia Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Thailand Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Indonesia Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Phillipines Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Rest of APAC Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Latin America Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Latin America Antisense & RNAI Therapeutics Market share analysis by country, 2022
FIGURE Brazil Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Mexico Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Argentina Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Colombia Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Rest of LATAM Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Middle East and Africa Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Middle East and Africa Antisense & RNAI Therapeutics Market share analysis by country, 2022
FIGURE Saudi Arabia Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE United Arab Emirates Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Israel Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Turkey Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Algeria Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Egypt Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Rest of MEA Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)